Tumor-infiltrating lymphocyte therapy: therapeutic advances and prospects
Tumor-infiltrating lymphocyte (TIL) therapy has evolved from a pioneering experimental approach to a clinically validated treatment strategy, underscored by the recent approval of lifileucel (Amtagvi) by the Food and Drug Administration (FDA) for advanced melanoma refractory to existing therapies. I...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
EDP Sciences
2025-01-01
|
| coleção: | Visualized Cancer Medicine |
| Assuntos: | |
| Acesso em linha: | https://vcm.edpsciences.org/articles/vcm/full_html/2025/01/vcm20250003/vcm20250003.html |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|